ESC 365 - New therapies for ATTR-CM, new patient expectations

Open Access

New therapies for ATTR-CM, new patient expectations

Session: ATTRibutes of change: advances in treating and monitoring ATTR-CM

Topic: Cardiomyopathies

Speaker: Professor M. Fontana (London, GB)

Sponsored by Bayer AG

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Professor Marianna Fontana

University College London, London (United Kingdom of Great Britain & Northern Ireland)

77 presentations

61 followers

6 more presentations in this session

Welcome and introduction

Speaker: Professor A. Ristic (Belgrade, RS)

From suspicion to ATTR-CM diagnosis: How do we streamline?

Speaker: Doctor P. Garcia-Pavia (Majadahonda, ES)

Linking serum TTR to patient outcomes in ATTR-CM

Speaker: Doctor L. Obici (Pavia, IT)

Practical insights from ATTR-CM patient cases

Speaker: Professor C. Tschoepe (Berlin, DE)

Panel discussion and Q&A

Access the full session

ATTRibutes of change: advances in treating and monitoring ATTR-CM

Speakers: Professor M. Fontana, Professor A. Ristic, Doctor P. Garcia-Pavia, Doctor L. Obici, Professor C. Tschoepe

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

novartis

Explore sponsored resources